Reliance Industries Ltd. is working on a new COVID-19 drug and cheaper testing kits as the conglomerate owned by Asia's richest man Mukesh Ambani looks to curb the pathogen which has ravaged India in the past year.
Read more about Reliance submits proposal for potential coronavirus drug Niclosamide on Business Standard. Reliance Industries Ltd s R&D arm has proposed the use of Niclosamide - the drug used to treat tapeworm infestation - for treating COVID-19 patients.Niclosamide, a drug on the World Health Organisation s list of essential medicines, has been used
India Business News: Richest Indian Mukesh Ambani drew no salary from his flagship firm Reliance Industries Ltd in the fiscal year ended March 31 as he voluntarily gave up
India is planning to ask for proposals from investment banks this month for the initial public offering of Life Insurance Corp. of India, according to people familiar with the matter.